Effect of Tiladi Churna (orally) with Vidangadi Lepa in the Management of Dadru Kushtha(Fungal Infection)

Efficacy of Tiladi Churna (orally) with Vidangadi Lepa in the Management of Dadru Kushtha- a Open Label Randomised Standard Control Study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064687

Enrollment

Registered

2024-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with classical sign and symptoms of Dadru Kushtha Patients willing to participate.

Exclusion criteria

Exclusion criteria: Patients suffering from Systemic Disorders, uncontrolled DM, HIV, Hepatitis- B, malignancy. Cases of Burn. Known cases of any other skin disease. Any allergic condition related to skin and hypersensitivity to any medicine. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Resolution in the sign and symptoms of Dadru kushthaTimepoint: Assessment of sign and symptoms of dadru kushtha at baseline,30th day,60th day	—

Secondary

Measure	Time frame
•To observe & determine the growth of fungus in Dadru kushtha by culture study. •To observe the Antifungal effect of Vidangadi lepa through sensitivity Timepoint: 1.Identification of fungus by microscopic examination using KOH(potassium hydroxide)10% at baseline 2.Assessment of Antifungal effect of Vidangadi lepa through sensitivity at baseline	—

Countries

India

Contacts

Public ContactDr Tadhani Piyush Lakhmanbhai

All India Institute Of Ayurveda

drmoreanand@gmail.com9422025732

Outcome results